Literature DB >> 8870971

Serine 752 in the cytoplasmic domain of the beta 3 integrin subunit is not required for alpha v beta 3 postreceptor signaling events.

N Kieffer1, C Melchior, J M Guinet, S Michels, V Gouon, N Bron.   

Abstract

A naturally occurring point mutation (Ser752Pro substitution) in the beta subunit cytoplasmic domain of the platelet fibrinogen receptor GPIIb-IIIa (integrin alpha IIb beta 3), causing Glanzmann's thrombasthenia, has been shown to abrogate bidirectional transmembrane signaling of GPIIb-IIIa when expressed in heterologous cells (Chen YP, 1994, Blood 84, 1857-1865). As the vitronectin receptor alpha v beta 3 constitutively mediates cell attachment to RGD containing extracellular matrix proteins, the purpose of this study was to explore the regulatory role of Ser752 in alpha v beta 3 vitronectin receptor function, by cotransfecting recombinant human alpha v cDNA together with human beta 3 mutant cDNA into Chinese hamster ovary (CHO) cells. CHO cells expressing wild type human alpha v beta 3 acquired the ability to attach and spread on fibrinogen and von Willebrand factor, in contrast to non transfected CHO cells that only bound to vitronectin and fibronectin. Overexpression of a truncated recombinant beta 3 subunit (beta 3 delta 744) generated alpha v (hamster) beta 3 (human) chimers that mediated attachment but lost the ability to promote cell spreading on vitronectin, von Willebrand factor and fibrinogen, and to concentrate in focal contact sites, demonstrating a negative effect of beta 3 delta 744 on alpha v beta 3 dependent postreceptor occupancy events. Transfection of beta 3Ser752Pro reproduced the same negative effect as beta 3 delta 744, whereas beta 3Ser752Ala restored normal receptor function by allowing pronounced attachment and spreading on fibrinogen and von Willebrand factor. Our results provide evidence that (1) the C-terminal cytoplasmic domain of beta 3 (amino acids 744-762) is essential for alpha v beta 3 integrin postreceptor occupancy events; (2) within this domain, the Ser752Pro mutation affects alpha v beta 3 postreceptor occupancy events by preventing cell spreading and focal contact localization; (3) the defective receptor function of the vitronectin receptor alpha v beta 3 is due to the presence of Pro752, rather than the absence of Ser752, as a Ser to Ala substitution at position 752 restores normal beta 3 integrin cell spreading and adhesive plaque formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870971     DOI: 10.3109/15419069609010761

Source DB:  PubMed          Journal:  Cell Adhes Commun        ISSN: 1023-7046


  5 in total

1.  Green fluorescent protein (GFP) tagged to the cytoplasmic tail of alphaIIb or beta3 allows the expression of a fully functional integrin alphaIIb(beta3): effect of beta3GFP on alphaIIb(beta3) ligand binding.

Authors:  S Plançon; M C Morel-Kopp; E Schaffner-Reckinger; P Chen; N Kieffer
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Identification of integrin beta subunit mutations that alter affinity for extracellular matrix ligand.

Authors:  Timmy Kendall; Leona Mukai; Alison L Jannuzi; Thomas A Bunch
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

3.  Activated αvβ3 integrin regulates αvβ5 integrin-mediated phagocytosis in trabecular meshwork cells.

Authors:  Debjani Gagen; Mark S Filla; Ross Clark; Paloma Liton; Donna M Peters
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-24       Impact factor: 4.799

4.  A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function.

Authors:  X Feng; D V Novack; R Faccio; D S Ory; K Aya; M I Boyer; K P McHugh; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

5.  Talin-bound NPLY motif recruits integrin-signaling adapters to regulate cell spreading and mechanosensing.

Authors:  Perrine Pinon; Jenita Pärssinen; Patricia Vazquez; Michael Bachmann; Rolle Rahikainen; Marie-Claude Jacquier; Latifeh Azizi; Juha A Määttä; Martin Bastmeyer; Vesa P Hytönen; Bernhard Wehrle-Haller
Journal:  J Cell Biol       Date:  2014-04-28       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.